Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4360

1.

Similar and Differing Distributions Between 18F-FDG-PET and Arterial Spin Labeling Imaging in Temporal Lobe Epilepsy.

Sone D, Maikusa N, Sato N, Kimura Y, Ota M, Matsuda H.

Front Neurol. 2019 Apr 3;10:318. doi: 10.3389/fneur.2019.00318. eCollection 2019.

2.

Oocyte collection and in vitro maturation after train transportation of human follicular fluid aspirated from resected non-stimulated ovaries of patients with endometrial adenocarcinoma.

Shirasawa H, Ono N, Kumazawa Y, Sato W, Sato N, Ihara M, Yaegashi N, Terada Y.

Reprod Med Biol. 2019 Jan 18;18(2):180-189. doi: 10.1002/rmb2.12265. eCollection 2019 Apr.

3.

Preoperative 1-week diet can markedly decrease blood loss during hepatectomy.

Kinoshita K, Beppu T, Sato N, Akahoshi S, Yuki H, Yoshida Y.

Transl Gastroenterol Hepatol. 2019 Mar 26;4:20. doi: 10.21037/tgh.2019.03.08. eCollection 2019. No abstract available.

4.

Advanced cadaver-based educational seminar for trauma surgery using saturated salt solution-embalmed cadavers.

Homma H, Oda J, Sano H, Kawai K, Koizumi N, Uramoto H, Sato N, Mashiko K, Yasumatsu H, Ito M, Fukuhara T, Watanabe Y, Kim S, Hayashi S, Kawata S, Miyawaki M, Miyaso H, Itoh M.

Acute Med Surg. 2019 Jan 20;6(2):123-130. doi: 10.1002/ams2.390. eCollection 2019 Apr.

5.

De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.

Tanaka S, Matsunami N, Morishima H, Oda N, Takashima T, Noda S, Kashiwagi S, Tauchi Y, Asano Y, Kimura K, Fujioka H, Terasawa R, Kawaguchi K, Ikari A, Morimoto T, Michishita S, Kobayashi T, Sakane J, Nitta T, Sato N, Hokimoto N, Nishida Y, Iwamoto M.

Cancer Chemother Pharmacol. 2019 Apr 8. doi: 10.1007/s00280-019-03836-z. [Epub ahead of print]

PMID:
30963212
6.

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication.

Ueno T, Saji S, Masuda N, Iwata H, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Sasano H, Toi M.

ESMO Open. 2019 Feb 27;4(1):e000476. doi: 10.1136/esmoopen-2018-000476. eCollection 2019.

7.

Oxytocin administration modulates rats' helping behavior depending on social context.

Yamagishi A, Okada M, Masuda M, Sato N.

Neurosci Res. 2019 Apr 3. pii: S0168-0102(19)30017-3. doi: 10.1016/j.neures.2019.04.001. [Epub ahead of print]

PMID:
30953682
8.

Five-year Recurrence-free Survival After Surgery Followed by Oral Chemotherapy for Gastric Cancer With Portal Vein Tumor Thrombosis.

Yoshida Y, Beppu T, Kinoshita K, Sato N, Akahoshi S, Yuki H, Saito S, Kitaoka M, Nasu J.

Anticancer Res. 2019 Apr;39(4):2233-2238. doi: 10.21873/anticanres.13339.

PMID:
30952772
9.

Subacute Sensory Ataxic Neuronopathy With Thymoma Presenting Marked Improvement After Steroid Therapy.

Nishijima H, Onodera K, Sato N, Ueno T, Hikichi H, Haga R, Arai A, Suzuki C, Nunomura JI, Baba M, Tomiyama M.

Front Neurol. 2019 Mar 20;10:268. doi: 10.3389/fneur.2019.00268. eCollection 2019.

10.

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.

Hamada S, Ichiyasu H, Ikeda T, Inaba M, Kashiwabara K, Sadamatsu T, Sato N, Akaike K, Okabayashi H, Saruwatari K, Tomita Y, Saeki S, Hirata N, Yoshinaga T, Fujii K.

BMC Pulm Med. 2019 Apr 2;19(1):72. doi: 10.1186/s12890-019-0838-2.

11.

Upstream Position of Proline Defines Peptide-HLA Class I Repertoire Formation and CD8+ T Cell Responses.

Hongo A, Kanaseki T, Tokita S, Kochin V, Miyamoto S, Hashino Y, Codd A, Kawai N, Nakatsugawa M, Hirohashi Y, Sato N, Torigoe T.

J Immunol. 2019 Apr 1. pii: ji1900029. doi: 10.4049/jimmunol.1900029. [Epub ahead of print]

PMID:
30936292
12.

The use of diffusional kurtosis imaging and neurite orientation dispersion and density imaging of the brain in bipolar disorder.

Ota M, Noda T, Sato N, Hidese S, Teraishi T, Setoyama S, Matsuda H, Kunugi H.

J Affect Disord. 2019 Mar 22;251:231-234. doi: 10.1016/j.jad.2019.03.068. [Epub ahead of print]

PMID:
30928862
13.

[Treatment Results and Strategies for Early Gastric Cancer Patients Aged 80 Years or Older-How Should We Deal withNon -Curative ESD Cases ?]

Takiguchi N, Nabeya Y, Ikeda A, Soda H, Tonooka T, Hoshino I, Iwadate Y, Sato N.

Gan To Kagaku Ryoho. 2019 Mar;46(3):490-492. Japanese.

PMID:
30914591
14.

Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study.

Okura Y, Takayama T, Ozaki K, Tanaka H, Kikuchi A, Saito T, Tanigawa T, Takii Y, Seki H, Takenouchi T, Chou T, Sato N, Tanabe N, Minamino T.

Int J Clin Oncol. 2019 Mar 22. doi: 10.1007/s10147-019-01426-w. [Epub ahead of print]

PMID:
30903421
15.

211At-labeled immunoconjugate via a one-pot three-component double click strategy: practical access to α-emission cancer radiotherapeutics.

Fujiki K, Kanayama Y, Yano S, Sato N, Yokokita T, Ahmadi P, Watanabe Y, Haba H, Tanaka K.

Chem Sci. 2018 Dec 21;10(7):1936-1944. doi: 10.1039/c8sc04747b. eCollection 2019 Feb 21.

16.

Short-time Fourier Transform of Free Induction Decays for the Analysis of Serum Using Proton Nuclear Magnetic Resonance.

Hirakawa K, Koike K, Kanawaku Y, Moriyama T, Sato N, Suzuki T, Furihata K, Ohno Y.

J Oleo Sci. 2019 Apr 1;68(4):369-378. doi: 10.5650/jos.ess18212. Epub 2019 Mar 13.

17.

Secondary sclerosing cholangitis with hemobilia induced by pembrolizumab: Case report and review of published work.

Koya Y, Shibata M, Shinohara N, Nebuya S, Oe S, Honma Y, Senju M, Sato N, Harada M.

Hepatol Res. 2019 Mar 12. doi: 10.1111/hepr.13329. [Epub ahead of print]

PMID:
30861263
18.

A polymorphism of the methylenetetrahydrofolate reductase gene confers susceptibility to schizophrenia and related brain changes.

Ota M, Sato N, Yoshida F, Hattori K, Hidese S, Teraishi T, Kunugi H.

Schizophr Res. 2019 Mar 6. pii: S0920-9964(19)30084-2. doi: 10.1016/j.schres.2019.03.002. [Epub ahead of print] No abstract available.

PMID:
30852115
19.

The unique tropism of Mycobacterium leprae to the nasal epithelial cells can be explained by the mammalian cell entry protein 1A.

Fadlitha VB, Yamamoto F, Idris I, Dahlan H, Sato N, Aftitah VB, Febriyanda A, Fujimura T, Takimoto H.

PLoS Negl Trop Dis. 2019 Mar 5;13(3):e0006704. doi: 10.1371/journal.pntd.0006704. eCollection 2019 Mar.

20.

Current status and future perspective on preclinical pharmacokinetic and pharmacodynamic (PK/PD) analysis: Survey in Japan pharmaceutical manufacturers association (JPMA).

Goto A, Abe S, Koshiba S, Yamaguchi K, Sato N, Kurahashi Y.

Drug Metab Pharmacokinet. 2019 Apr;34(2):148-154. doi: 10.1016/j.dmpk.2019.01.004. Epub 2019 Jan 29.

PMID:
30827921

Supplemental Content

Loading ...
Support Center